Artivion Inc (AORT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Artivion Inc (AORT) has a cash flow conversion efficiency ratio of 0.003x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.15 Million) by net assets ($450.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Artivion Inc balance sheet independence to measure how much of total assets are equity-financed.
Artivion Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Artivion Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Artivion Inc (AORT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Artivion Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Artivion Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Siglent Technologies Co Ltd
SHG:688112
|
0.023x |
|
Stepan Company
NYSE:SCL
|
0.056x |
|
Beijing New Space Technology Co Ltd
SHG:605178
|
0.001x |
|
Suofeiya Home Collection Co Ltd
SHE:002572
|
-0.038x |
|
BrightView Holdings
NYSE:BV
|
0.026x |
|
M. Dias Branco S.A. Indústria e Comércio de Alimentos
SA:MDIA3
|
0.023x |
|
SINOTRANS LTD H YC 1
F:SIY
|
0.020x |
|
Focus Technology Co Ltd
SHE:002315
|
0.075x |
Annual Cash Flow Conversion Efficiency for Artivion Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of Artivion Inc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see AORT stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $448.23 Million | $38.13 Million | 0.085x | +5.66% |
| 2024-12-31 | $276.20 Million | $22.24 Million | 0.081x | +20.51% |
| 2023-12-31 | $281.78 Million | $18.82 Million | 0.067x | +468.63% |
| 2022-12-31 | $284.33 Million | $-5.15 Million | -0.018x | -110.84% |
| 2021-12-31 | $300.73 Million | $-2.58 Million | -0.009x | -122.84% |
| 2020-12-31 | $328.71 Million | $12.37 Million | 0.038x | -32.08% |
| 2019-12-31 | $285.70 Million | $15.83 Million | 0.055x | +54.22% |
| 2018-12-31 | $275.07 Million | $9.88 Million | 0.036x | -7.22% |
| 2017-12-31 | $279.04 Million | $10.80 Million | 0.039x | -58.97% |
| 2016-12-31 | $208.98 Million | $19.72 Million | 0.094x | +28.03% |
| 2015-12-31 | $155.25 Million | $11.44 Million | 0.074x | +34.99% |
| 2014-12-31 | $148.69 Million | $8.12 Million | 0.055x | -52.88% |
| 2013-12-31 | $144.75 Million | $16.77 Million | 0.116x | -21.83% |
| 2012-12-31 | $128.11 Million | $18.99 Million | 0.148x | +7.55% |
| 2011-12-31 | $121.54 Million | $16.75 Million | 0.138x | -24.63% |
| 2010-12-31 | $113.94 Million | $20.84 Million | 0.183x | +21.88% |
| 2009-12-31 | $110.45 Million | $16.57 Million | 0.150x | +56.27% |
| 2008-12-31 | $99.33 Million | $9.54 Million | 0.096x | -35.29% |
| 2007-12-31 | $62.63 Million | $9.29 Million | 0.148x | +821.60% |
| 2006-12-31 | $52.09 Million | $-1.07 Million | -0.021x | +94.38% |
| 2005-12-31 | $50.62 Million | $-18.52 Million | -0.366x | -11.95% |
| 2004-12-31 | $49.66 Million | $-16.23 Million | -0.327x | -166.25% |
| 2003-12-31 | $48.34 Million | $-5.93 Million | -0.123x | -363.90% |
| 2002-12-31 | $79.80 Million | $-2.11 Million | -0.026x | -141.42% |
| 2001-12-31 | $101.44 Million | $6.48 Million | 0.064x | -44.45% |
| 2000-12-31 | $89.39 Million | $10.28 Million | 0.115x | +834.62% |
| 1999-12-31 | $80.23 Million | $987.00K | 0.012x | -17.57% |
| 1998-12-31 | $80.40 Million | $1.20 Million | 0.015x | +120.49% |
| 1997-12-31 | $30.20 Million | $-2.20 Million | -0.073x | -145.35% |
| 1996-12-31 | $24.90 Million | $4.00 Million | 0.161x | +199.38% |
| 1995-12-31 | $20.50 Million | $1.10 Million | 0.054x | -63.06% |
| 1994-12-31 | $17.90 Million | $2.60 Million | 0.145x | +220.56% |
| 1993-12-31 | $16.60 Million | $-2.00 Million | -0.120x | +65.43% |
| 1991-12-31 | $6.60 Million | $-2.30 Million | -0.348x | -- |
About Artivion Inc
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid… Read more